Nemus Bioscience Adds to Senior Leadership Team
May 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
LONG BEACH, CA, May 07, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
Prominent Salk Institute Neuroscientist Joins Nemus Bioscience as Scientific Consultant
March 21, 2018 08:30 ET
|
Nemus Bioscience, Inc.
Dr. David Schubert to advise Nemus on neuroprotection and CNS applications of the company’s proprietary cannabinoid portfolio COSTA MESA, CA. , March 21, 2018 (GLOBE NEWSWIRE) -- Nemus...
NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at the New York Academy of Sciences
March 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
COSTA MESA, CA., March 07, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Emerald Health, Strategic Majority Investor in Nemus Bioscience, Completes Final Closing of Private Placement Investment Ahead of Schedule
February 16, 2018 17:24 ET
|
Nemus Bioscience, Inc.
Nemus Bioscience Receives $1,750,000 Private Placement to Help Advance Innovative Bio-engineered Cannabinoid Pipeline Costa Mesa, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc....
NEMUS Bioscience to Participate in BIO CEO Investor Conference to Provide Ophthalmology-Focused Pipeline Review
February 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
COSTA MESA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Nemus Secures Emerald Health as Strategic Majority Investor to help Advance Clinical Development of Novel Cannabinoid-based Therapeutics
January 19, 2018 08:30 ET
|
Nemus Bioscience, Inc.
Nemus Bioscience Receives $400,000 Funding under Convertible Bridge Loan and Closes Initial $1,500,000 Private Placement COSTA MESA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc....
Nemus Bioscience Announces Closing of Convertible Bridge Loan and Anticipated Equity Financing
December 29, 2017 08:30 ET
|
Nemus Bioscience, Inc.
COSTA MESA, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS, “Nemus”) today announced that it entered into agreements with Emerald Health Sciences Inc. (“Emerald”),...